DCSIMG

Revolutionising stem cell research

CEO of Orbsen Therapeutics, Brian Molly (right), pictured with Head of Research, Dr Stephen J Elliman, and founding director and CSO, Prof Frank Barry. Photo: Arun K Konattu

CEO of Orbsen Therapeutics, Brian Molly (right), pictured with Head of Research, Dr Stephen J Elliman, and founding director and CSO, Prof Frank Barry. Photo: Arun K Konattu

A company led by a Longford native has been nominated for an Irish Times IntraTradeireland Innovation Award for its work in stem cell research.

“We’re delighted just to be nominated,” admitted Brian Molloy from Lanesboro, who is the CEO of the Galway-based company, Orbsen Therepeutics.

Mr Molloy explained that Orbsen’s research into stem cells differs from more recognised methods.

“We have found a new method of isolating adult stem cells,” he revealed, adding that he is hopeful this will eliminate moral issues associated with existing methods, which use cells extracted from human embryos.

“We extract a piece of bone marrow from an adult, and use a specific protein to isolate the therepueutic cells,” he said. “This can then be split and grown to therepeutic levels.”

Mr Molloy is hopeful that when the company reaches the clinical trials stage, the results will show benefits to people living with conditions such as diabetes and liver disease.

“We won’t have a clear idea until it’s brought to clinical trials, but we have sufficient data to indicate the research is worthwhile.”

 

Comments

 
 

Back to the top of the page